These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17072461)

  • 21. [Persistence of immune memory to hepatitis B vaccine among infants with normal or high antibody response to primary vaccination: a five-year following-up study].
    Zhang L; Yan B; Liu J; Lyu J; Feng Y; Xu A; Song L; Liang X; Li L; Cui F; Zhang G; Wang F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1372-6. PubMed ID: 26850392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
    Das K; Gupta RK; Kumar V; Kar P
    World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with vaccine prophylaxis of hepatitis B among different groups of children].
    Moskovskaia IA; Kuzina LE; Anichkina TV; Aleshin IK; Ul'ianova LA; Kuzin SN
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (2):42-6. PubMed ID: 12886606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
    Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The vaccinal prophylaxis of hepatitis B among children born to mothers with persistent HBs-antigenemia].
    Khukhlovich PA; Shakhgil'dian IV; Narkevich MI; Anan'ev VA; Kuzin SN; Sergeeva NA; Khodzhaev ShKh; Iarovoĭ PI; Drobeniuk ZhA; Iuldashev AK; Khodzhaeva MA; Makmudova ON; Buriev AIa; Rakhimov RA; Tuliaganova GM; Khasanova VA; Tsvaĭner MI; Eliseeva TS; Tuĭchibaeva MA; Mineecheva LV; Kotsaga EI; Nagachevskaia VI; Rafikova NKh; Klimenko SM
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):55-9. PubMed ID: 8701658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
    Bassily S; Kotkat A; Gray G; Hyams KC; Brown FM; Imam IZ; Arthur R
    Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up].
    Zhang L; Zhang W; Lyu JJ; Zhang JJ; Liu JY; Yan BY; Feng Y; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1156-1160. PubMed ID: 28910922
    [No Abstract]   [Full Text] [Related]  

  • 33. Duration of protection after infant hepatitis B vaccination series.
    Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
    Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the anti-hepatitis B vaccination efficacy in high risk children.
    Nedelcu I; Crăciun D; Târdei G; Ruţă SM; Grancea C; Cernescu C
    Rom J Virol; 1998; 49(1-4):43-51. PubMed ID: 10892425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
    Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
    [No Abstract]   [Full Text] [Related]  

  • 37. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M; Marczyńska M
    Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison on the antibody response after primary immunization of 5 µg and 10 µg hepatitis B vaccine made by recombinant DNA techniques among newborns].
    Zhang L; Zhang W; Zhai XJ; Li YP; Li J; Yan BY; Li YT; Zhu FC; Huang T; Li LQ; Gong XH; Cui FQ; Liang XF; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):305-8. PubMed ID: 22613384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.